TALPHERA INC
TLPH · NASDAQ
Updated at 2026-10-14 09:20:46
- Today's High
- $1.08
- Today’s Low
- $1.05
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.09
- Previous Close
- $1.08
- Volume
- 26.54K
- Market Cap
- $56.05M
- P/E Ratio
- --
- EPS
- $-0.25
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- DRUG MANUFACTURERS - SPECIALTY & GENERIC
- Headquarters
- 1850 GATEWAY DRIVE, SAN MATEO, CA, UNITED STATES, 94404
- Country
- US
- Listing Date
- 2011-02-11
- Fiscal Year End
- December
- Shares Outstanding
- 51.9M
- CIK
- 0001427925
- Website
- talphera.com
Talphera Inc. is a pioneering biotechnology company dedicated to advancing peptide-based therapies for rare diseases and significant unmet medical needs. Its promising pipeline, especially in developing innovative cancer treatments, highlights the firm's potential for substantial growth within the biopharmaceutical industry. Committed to rigorous research and focused on delivering transformative health solutions, Talphera represents a compelling investment opportunity for institutional investors seeking to capitalize on the dynamic biotech landscape.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$1K
Operating Expenses
2026-06-30
$3.92M
2026-03-31
$3.94M
2025-12-31
$3.45M
2025-09-30
$3.42M
Net Income
2026-06-30
-$4.31M
2026-03-31
-$2.55M
2025-12-31
-$3.77M
2025-09-30
-$4.43M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
-443.6K%
Earnings Per Share
2026-06-30
$-0.06
2026-03-31
$-0.05
2025-12-31
$-0.06
2025-09-30
$-0.11
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$3.36M
2026-03-31
-$2.55M
2025-12-31
-$3.77M
2025-09-30
-$4.43M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $1K |
| Operating Expenses | $3.92M | $3.94M | $3.45M | $3.42M |
| Net Income | -$4.31M | -$2.55M | -$3.77M | -$4.43M |
| Net Profit Margin | -- | -- | -- | -443.6K% |
| Earnings Per Share | $-0.06 | $-0.05 | $-0.06 | $-0.11 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$3.36M | -$2.55M | -$3.77M | -$4.43M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.